Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neumann

Showing results (501-510 of 22,095) with videos related to

Pageof 2,210
Sort By:
Nephrology News & Issues|April 7, 2011
ESRD demonstration aligns incentivesMark E Neumann
Nephrology News & Issues|April 7, 2011
Translating the benefit of the FHN trialMark E Neumann
Nephrology News & Issues|May 6, 2011
GAO looks at bundling outside ESRDMark E Neumann
Nephrology News & Issues|October 18, 2011
And then there were--?Mark E Neumann
Critical Reviews in Toxicology|June 24, 2009
Risk assessment of chemical carcinogens and thresholdsHans-Günter Neumann
Fogorvosi Szemle|July 1, 1986
[Orthodontic therapy of deciduous dentition]D Dausch-Neumann
Journal of Cancer Research and Clinical Oncology|January 1, 1986
The role of DNA damage in chemical carcinogenesis of aromatic aminesH G Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 1, 2021
Toward Better Data Dashboards for US Drug Value AssessmentsPeter J Neumann
The Journal of Clinical Psychiatry|March 12, 1999
Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: implications for schizophrenia treatmentP J Neumann
Health Care Law Newsletter|July 7, 1995
Telemedicine--the diagnostic tool of the futureP G Neumann
Pageof 2,210

Showing results (501-510 of 22,095) with videos related to

Sort By:
Pageof 2,210
Nephrology News & Issues|April 7, 2011
ESRD demonstration aligns incentivesMark E Neumann
Nephrology News & Issues|April 7, 2011
Translating the benefit of the FHN trialMark E Neumann
Nephrology News & Issues|May 6, 2011
GAO looks at bundling outside ESRDMark E Neumann
Nephrology News & Issues|October 18, 2011
And then there were--?Mark E Neumann
Critical Reviews in Toxicology|June 24, 2009
Risk assessment of chemical carcinogens and thresholdsHans-Günter Neumann
Fogorvosi Szemle|July 1, 1986
[Orthodontic therapy of deciduous dentition]D Dausch-Neumann
Journal of Cancer Research and Clinical Oncology|January 1, 1986
The role of DNA damage in chemical carcinogenesis of aromatic aminesH G Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 1, 2021
Toward Better Data Dashboards for US Drug Value AssessmentsPeter J Neumann
The Journal of Clinical Psychiatry|March 12, 1999
Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: implications for schizophrenia treatmentP J Neumann
Health Care Law Newsletter|July 7, 1995
Telemedicine--the diagnostic tool of the futureP G Neumann
Pageof 2,210